Aggressive HER2+ breast cancer [infographic]
Today marks the beginning of the annual Breast Cancer Awareness Month taking place worldwide. In 2018 alone, two million people are estimated to be diagnosed with breast cancer; 10-30% with the aggressive subtype HER2+, which has a serious clinical concern of treatment resistance. We analyzed the statistics and compiled an infographic.
October 1, 2018
Our success depends on how well our clients perform. We are here to equip them with the right tools and empower them with the right insight, so they confidently can strike deals, partnerships and attract investments.
We understand the business issues facing smaller biotech companies and share a passion with our clients to drive the future of medicine.
We support leaders with actionable recommendations and insights with a fervor and razor-sharp focus. Our approach is doing so by creating tailored solutions to challenging business issues and crafting strategies to achieve business goals and brand visibility. Whether it is business development, asset valuation or communication, we are a reliable partner that always walk that extra mile.